Loading...

Home
ETF
INKT

INKT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

INKT News

SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm

2d agoNASDAQ.COM

MiNK Therapeutics Doses First Patient, Launching New Therapy for Acute Lung Injury

2d agoNewsfilter

Noetik's TARIO-2 Platform Reveals Tumor Microenvironment Patterns

May 21 2026Newsfilter

MiNK Therapeutics Releases New Clinical Data on agenT-797 and N-803 Combination Therapy

May 20 2026Newsfilter

MiNK Therapeutics Q1 2026 Earnings Call Insights

May 15 2026seekingalpha

Agenus Reports New Data on HCC Treatment

May 15 2026Newsfilter

MiNK Therapeutics Q1 Earnings Beat Expectations

May 15 2026seekingalpha

MiNK Therapeutics Initiates Phase 2 Trial for agenT-797 in Severe Lung Injury

May 15 2026Newsfilter

MiNK Initiates iNKT Cell Therapy Trial for Acute Lung Injury

May 14 2026Newsfilter

MiNK Therapeutics' iNKT Therapy Shows Promise in Cancer and ARDS

May 12 2026Newsfilter

MiNK Therapeutics to Report Q1 2026 Financial Results

May 08 2026Newsfilter

MiNK Therapeutics Reports Promising Results in Gastroesophageal Cancer Study

Apr 17 2026Newsfilter

MiNK Therapeutics Unveils New Data on iNKT Cell Therapy

Apr 03 2026Newsfilter

MiNK Therapeutics' iNKT Cell Therapy Accepted for ASGCT Presentation

Apr 02 2026Newsfilter

MiNK Therapeutics' iNKT Cell Therapy Accepted for ATS Conference Presentation

Apr 01 2026Newsfilter

MiNK Therapeutics Financial and Clinical Progress Update

Mar 31 2026Yahoo Finance